Article
The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.
British journal of pharmacology - 1 Apr 2009
van der Hoorn J W A, Jukema J W, Havekes L M, Lundholm E, Camejo G, Rensen P C N, Princen H M G
Abstract excerpt
BACKGROUND AND PURPOSE: We have evaluated the effects of a peroxisome proliferator-activated receptor (PPAR)alpha/gamma agonist on the progression of pre-existing atherosclerotic lesions in APOE*3Leiden.cholesteryl ester transfer protein (E3L.CETP) transgenic mice. EXPERIMENTAL APPROACH: E3L.CETP mice were fed a high-cholesterol diet for 11 weeks to induce atherosclerosis, followed by a low-cholesterol diet for 4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
